KURA ONCOLOGY, INC.

(KURA)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
12.59 USD   +3.79%
05/04KURA ONCOLOGY : Q1 Earnings Snapshot
AQ
05/04KURA ONCOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
05/04TRANSCRIPT : Kura Oncology, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about KURA ONCOLOGY, INC.
05/04KURA ONCOLOGY : Q1 Earnings Snapshot
AQ
05/04TRANSCRIPT : Kura Oncology, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Kura Oncology Reports First Quarter 2022 Financial Results
AQ
05/04Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/27Kura Oncology to Report First Quarter 2022 Financial Results
AQ
04/08Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergenc..
AQ
04/08Kura Oncology, Inc. Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Em..
CI
03/15TRANSCRIPT : Kura Oncology, Inc. Presents at Barclays Global Healthcare Conference 2022, M..
CI
03/08Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Mee..
AQ
02/28Kura Oncology to Participate in Two Upcoming Investor Conferences
AQ
02/25SVB Leerink Lowers Kura Oncology's Price Target to $28 From $41, Maintains Outperform R..
MT
02/25Credit Suisse Lifts Kura Oncology's Price Target to $27 from $25, Notes Rich Catalyst L..
MT
02/24KURA ONCOLOGY : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K
PU
02/24KURA ONCOLOGY : Q4 Earnings Snapshot
AQ
02/24TRANSCRIPT : Kura Oncology, Inc., Q4 2021 Earnings Call, Feb 24, 2022
CI
More most relevant news
All news about KURA ONCOLOGY, INC.
05/04KURA ONCOLOGY : Q1 Earnings Snapshot
AQ
05/04KURA ONCOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
05/04TRANSCRIPT : Kura Oncology, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Kura Oncology Reports First Quarter 2022 Financial Results
AQ
05/04Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/27Kura Oncology to Report First Quarter 2022 Financial Results
AQ
04/08Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergenc..
AQ
04/08Kura Oncology, Inc. Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Em..
CI
03/15TRANSCRIPT : Kura Oncology, Inc. Presents at Barclays Global Healthcare Conference 2022, M..
CI
03/08Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Mee..
AQ
More news
News in other languages on KURA ONCOLOGY, INC.
05/04Kura Oncology, Inc. annonce ses résultats pour le premier trimestre se terminant le 31 ..
04/08Kura Oncology, Inc. rapporte des données précliniques soutenant l'utilisation du Tipifa..
02/24Kura Oncology, Inc. annonce ses résultats pour l'année complète se terminant le 31 déce..
02/24Kura Oncology, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décemb..
02/07Alector nomme Marc Grasso au poste de directeur financier
02/02Marc Grasso, directeur financier de Kura Oncology, quitte son poste
02/01Kura Oncology, Inc. annonce des changements de direction
01/20La FDA lève la suspension de l'étude de phase 1b KOMET-001 de Kura Oncology sur les pat..
01/20Kura Oncology, Inc. reçoit l'autorisation de la FDA de procéder à l'étude de phase 1b d..
2021Kura Oncology commence le dosage dans l'essai clinique de phase 1/2 d'une bithérapie po..
More news
Analyst Recommendations on KURA ONCOLOGY, INC.
02/25SVB Leerink Lowers Kura Oncology's Price Target to $28 From $41, Maintains Outperform R..
MT
02/25Credit Suisse Lifts Kura Oncology's Price Target to $27 from $25, Notes Rich Catalyst L..
MT
02/15Jefferies Financial Initiates Kura Oncology at Buy, Sets Price Target at $35
MT
02/14Credit Suisse Lifts Kura Oncology's Price Target to $25 from $21, Maintains Outperform ..
MT
2021Credit Suisse Adjusts Kura Oncology's Price Target to $21 From $40, Keeps Outperform Ra..
MT
More recommendations
Press releases
05/04KURA ONCOLOGY : Q1 Earnings Snapshot
AQ
05/04KURA ONCOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
05/04Kura Oncology Reports First Quarter 2022 Financial Results
AQ
04/27Kura Oncology to Report First Quarter 2022 Financial Results
AQ
04/08Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergenc..
AQ
More press releases
Upcoming event on KURA ONCOLOGY, INC.